266 related articles for article (PubMed ID: 11014406)
1. Pharmacokinetics of nicotine in kidney failure.
Molander L; Hansson A; Lunell E; Alainentalo L; Hoffmann M; Larsson R
Clin Pharmacol Ther; 2000 Sep; 68(3):250-60. PubMed ID: 11014406
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of nicotine in healthy elderly people.
Molander L; Hansson A; Lunell E
Clin Pharmacol Ther; 2001 Jan; 69(1):57-65. PubMed ID: 11180039
[TBL] [Abstract][Full Text] [Related]
3. Nicotine-mecamylamine interactions.
Zevin S; Jacob P; Benowitz NL
Clin Pharmacol Ther; 2000 Jul; 68(1):58-66. PubMed ID: 10945316
[TBL] [Abstract][Full Text] [Related]
4. Disposition of didanosine in HIV-seropositive patients with normal renal function or chronic renal failure: influence of hemodialysis and continuous ambulatory peritoneal dialysis.
Knupp CA; Hak LJ; Coakley DF; Falk RJ; Wagner BE; Raasch RH; van der Horst CM; Kaul S; Barbhaiya RH; Dukes GE
Clin Pharmacol Ther; 1996 Nov; 60(5):535-42. PubMed ID: 8941026
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics in renally impaired subjects of NXY-059, a nitrone-based, free-radical trapping agent developed for the treatment of acute stroke.
Strid S; Borgå O; Edenius C; Jostell KG; Odergren T; Weil A
Eur J Clin Pharmacol; 2002 Sep; 58(6):409-15. PubMed ID: 12242600
[TBL] [Abstract][Full Text] [Related]
6. Important differentiation of factors that predict outcome in peritoneal dialysis patients with different degrees of residual renal function.
Wang AY; Woo J; Wang M; Sea MM; Sanderson JE; Lui SF; Li PK
Nephrol Dial Transplant; 2005 Feb; 20(2):396-403. PubMed ID: 15187196
[TBL] [Abstract][Full Text] [Related]
7. Effects of smoking on the pharmacokinetics and pharmacodynamics of a nicotine patch.
Yun HY; Seo JW; Choi JE; Baek IH; Kang W; Kwon KI
Biopharm Drug Dispos; 2008 Dec; 29(9):521-8. PubMed ID: 19054833
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of lenalidomide in subjects with various degrees of renal impairment and in subjects on hemodialysis.
Chen N; Lau H; Kong L; Kumar G; Zeldis JB; Knight R; Laskin OL
J Clin Pharmacol; 2007 Dec; 47(12):1466-75. PubMed ID: 17954615
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of nicotine, cotinine, and 3'-hydroxycotinine in cigarette smokers.
Scherer G; Jarczyk L; Heller WD; Biber A; Neurath GB; Adlkofer F
Klin Wochenschr; 1988; 66 Suppl 11():5-11. PubMed ID: 3184779
[TBL] [Abstract][Full Text] [Related]
10. Cotinine effects on nicotine metabolism.
Zevin S; Jacob P; Benowitz N
Clin Pharmacol Ther; 1997 Jun; 61(6):649-54. PubMed ID: 9209247
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of fleroxacin in renal impairment.
Weidekamm E
Am J Med; 1993 Mar; 94(3A):70S-74S. PubMed ID: 8452185
[TBL] [Abstract][Full Text] [Related]
12. Garenoxacin pharmacokinetics in subjects with renal impairment.
Krishna G; Gajjar D; Swan S; Marbury T; Grasela DM; Wang Z
Curr Med Res Opin; 2007 Mar; 23(3):649-57. PubMed ID: 17355746
[TBL] [Abstract][Full Text] [Related]
13. Effect of renal impairment on the pharmacokinetics and pharmacodynamics of desirudin.
Lefèvre G; Duval M; Gauron S; Brookman LJ; Rolan PE; Morris TM; Piraino AJ; Morgan JM; Palmisano M; Close P
Clin Pharmacol Ther; 1997 Jul; 62(1):50-9. PubMed ID: 9246019
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of single-dose rosiglitazone in chronic ambulatory peritoneal dialysis patients.
Aramwit P; Supasyndh O; Sriboonruang T
J Clin Pharm Ther; 2008 Dec; 33(6):685-90. PubMed ID: 19138247
[TBL] [Abstract][Full Text] [Related]
15. Evolution of residual renal function in patients undergoing maintenance haemodialysis or continuous ambulatory peritoneal dialysis.
Rottembourg J; Issad B; Gallego JL; Degoulet P; Aime F; Gueffaf B; Legrain M
Proc Eur Dial Transplant Assoc; 1983; 19():397-403. PubMed ID: 6878254
[TBL] [Abstract][Full Text] [Related]
16. Arteriovenous differences in plasma concentration of nicotine and catecholamines and related cardiovascular effects after smoking, nicotine nasal spray, and intravenous nicotine.
Gourlay SG; Benowitz NL
Clin Pharmacol Ther; 1997 Oct; 62(4):453-63. PubMed ID: 9357397
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of clodronate in renal failure.
Saha H; Castren-Kortekangas P; Ojanen S; Juhakoski A; Tuominen J; Tokola O; Pasternack A
J Bone Miner Res; 1994 Dec; 9(12):1953-8. PubMed ID: 7872061
[TBL] [Abstract][Full Text] [Related]
18. [Differences between the glomerular filtration rate estimated by the MDRD equation and the measurement of creatinine and urea clearance in unselected patients with terminal renal insufficiency].
Caravaca F; Arrobas M; Luna E; Naranjo M; Pizarro JL; Sánchez-Casado E
Nefrologia; 2002; 22(5):432-7. PubMed ID: 12497744
[TBL] [Abstract][Full Text] [Related]
19. Female sex and oral contraceptive use accelerate nicotine metabolism.
Benowitz NL; Lessov-Schlaggar CN; Swan GE; Jacob P
Clin Pharmacol Ther; 2006 May; 79(5):480-8. PubMed ID: 16678549
[TBL] [Abstract][Full Text] [Related]
20. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
